159 related articles for article (PubMed ID: 32872192)
1. The Impact of Ang-(1-9) and Ang-(3-7) on the Biological Properties of Prostate Cancer Cells by Modulation of Inflammatory and Steroidogenesis Pathway Genes.
Domińska K; Kowalska K; Urbanek KA; Habrowska-Górczyńska DE; Ochędalski T; Piastowska Ciesielska AW
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872192
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin 1-7 modulates molecular and cellular processes central to the pathogenesis of prostate cancer.
Domińska K; Okła P; Kowalska K; Habrowska-Górczyńska DE; Urbanek KA; Ochędalski T; Piastowska-Ciesielska AW
Sci Rep; 2018 Oct; 8(1):15772. PubMed ID: 30361641
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mRNA gene expression of members of the NF-κB transcription factor gene family by angiotensin II and relaxin 2 in normal and cancer prostate cell lines.
Domińska K; Kowalska K; Matysiak ZE; Płuciennik E; Ochędalski T; Piastowska-Ciesielska AW
Mol Med Rep; 2017 Jun; 15(6):4352-4359. PubMed ID: 28487955
[TBL] [Abstract][Full Text] [Related]
4. Similarities and differences between effects of angiotensin III and angiotensin II on human prostate cancer cell migration and proliferation.
Domińska K; Piastowska-Ciesielska AW; Lachowicz-Ochędalska A; Ochędalski T
Peptides; 2012 Oct; 37(2):200-6. PubMed ID: 22884921
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 induces changes in the expression levels of steroidogenic enzymes and increases androgen receptor and testosterone production in the PC3 prostate cancer cell line.
Torres MJ; López-Moncada F; Herrera D; Indo S; Lefian A; Llanos P; Tapia J; Castellón EA; Contreras HR
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34165174
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.
Cao F; Jin TY; Zhou YF
Biomed Environ Sci; 2006 Feb; 19(1):35-41. PubMed ID: 16673816
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
8. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
Chow L; Rezmann L; Imamura K; Wang L; Catt K; Tikellis C; Louis WJ; Frauman AG; Louis SN
Prostate; 2008 May; 68(6):651-60. PubMed ID: 18288685
[TBL] [Abstract][Full Text] [Related]
9. Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells.
Domińska K; Ochędalski T; Kowalska K; Matysiak-Burzyńska ZE; Płuciennik E; Piastowska-Ciesielska AW
Int J Oncol; 2016 Jun; 48(6):2619-28. PubMed ID: 27035428
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.
Krishnan B; Torti FM; Gallagher PE; Tallant EA
Prostate; 2013 Jan; 73(1):60-70. PubMed ID: 22644934
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
12. Bakuchiol exhibits anti-metastasis activity through NF-κB cross-talk signaling with AR and ERβ in androgen-independent prostate cancer cells PC-3.
Miao L; Yun X; Tao R; Wang Y; Fan G; Zhu Y; Cai T; Zhu Z; Yan C; Gao X
J Pharmacol Sci; 2018 Sep; 138(1):1-8. PubMed ID: 30236540
[TBL] [Abstract][Full Text] [Related]
13. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA].
Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells.
Li H; Qi Y; Li C; Braseth LN; Gao Y; Shabashvili AE; Katovich MJ; Sumners C
Mol Cancer Ther; 2009 Dec; 8(12):3255-65. PubMed ID: 19996275
[TBL] [Abstract][Full Text] [Related]
15. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
17. The opposite effects of angiotensin 1-9 and angiotensin 3-7 in prostate epithelial cells.
Domińska K; Kowalska K; Habrowska-Górczyńska DE; Urbanek KA; Ochędalski T; Piastowska-Ciesielska AW
Biochem Biophys Res Commun; 2019 Nov; 519(4):868-873. PubMed ID: 31563322
[TBL] [Abstract][Full Text] [Related]
18. Expression of melanocortin receptors in human prostate cancer cell lines: MC2R activation by ACTH increases prostate cancer cell proliferation.
Hafiz S; Dennis JC; Schwartz D; Judd R; Tao YX; Khazal K; Akingbemi B; Mo XL; Abdel-Mageed AB; Morrison E; Mansour M
Int J Oncol; 2012 Oct; 41(4):1373-80. PubMed ID: 22842514
[TBL] [Abstract][Full Text] [Related]
19. ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.
Singh N; Joshi S; Guo L; Baker MB; Li Y; Castellano RK; Raizada MK; Jarajapu YP
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1697-707. PubMed ID: 26386115
[TBL] [Abstract][Full Text] [Related]
20. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
